About Dr. Stanislaw R. Burzynski
Stanislaw R. Burzynski, M.D., Ph.D., internationally recognized physician and biochemist-researcher who pioneered the development and use of biologically active peptides in diagnosing, preventing and treating cancer, since 1967.
In 1967, at the young age of 24, S.R. Burzynski graduated from the Medical Academy in Lublin, Poland, with a M.D. degree with distinction, finishing first in his class of 250. During the same year he identified naturally occurring peptides in the human body which he concluded control cancer growth. He found that there is a marked deficiency of these peptides in cancer patients.
The following year, 1968, he earned his Ph.D. in Biochemistry as one of the youngest candidates in Poland ever to hold both an M.D. and Ph.D.
From 1970 to 1977, while a researcher and Assistant Professor at Baylor College of Medicine in Houston, his research was sponsored and partially funded by the National Cancer Institute. At Baylor, he authored and co-authored 16 publications, including 5 concerning his research on peptides and their effect on human cancer. Four of these publications were also co-authored by other doctors associated with M.D. Anderson Hospital and Tumor Institute, and Baylor College of Medicine.
In May of 1977, Dr. Burzynski received a Certificate of Appreciation from Baylor College of Medicine, commending him for completing five years of dedicated service and acknowledging his contributions made to the "Advancement of Medical Education, Research, and Health Care."
That same year, Dr. Burzynski founded his clinic in Houston where he's since treated over 8,000 patients. Dr. Burzynski is a member in good standing of renowned medical associations, including the American and World Medical Associations, American Association for Cancer Research, Society for Neuroscience, Texas Medical Association, Royal Medical Association (U.K.), Academy of Medical Ethics, Society for Neuro-Oncology, and many others.
Dr. Burzynski is the author and co-author of over 300 scientific publications and presentations. In his career he has received numerous prestigious awards from various medical, educational and governmental institutions. Currently, he holds 242 patents registered in 35 countries, related to 17 proprietary scientific inventions (as of January 2011).
Dr. Burzynski has collaborated with researchers at the National Cancer Institute, the Medical College of Georgia, the Imperial College of Science and Technology of London, the University of Kurume Medical School in Japan, the University of Turin Medical School in Italy, and others.